Effects on bioactivity due to C-5 heteroatom substituents on synthetic 28-homobrassinosteroid analogs
Five new 28-homobrassinosteroids have been synthesized, namely, (22R,23R)-5-fluoro-3α,22,23-trihydroxy-5α-stigmastan-6-one, (22R,23R)-5-fluoro-3β,22,23-trihydroxy-5α-stigmastan-6-one, (22R,23R)-5-fluoro-2α,3α,22,23-tetrahydroxy-5α-stigmastan-6-one, (22R,23R)-3α,5,22,23-tetrahydroxy-5α-stigmastan-6-o...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_00404020_v56_n34_p6171_Ramirez |
Aporte de: |
Sumario: | Five new 28-homobrassinosteroids have been synthesized, namely, (22R,23R)-5-fluoro-3α,22,23-trihydroxy-5α-stigmastan-6-one, (22R,23R)-5-fluoro-3β,22,23-trihydroxy-5α-stigmastan-6-one, (22R,23R)-5-fluoro-2α,3α,22,23-tetrahydroxy-5α-stigmastan-6-one, (22R,23R)-3α,5,22,23-tetrahydroxy-5α-stigmastan-6-one and (22R,23R)-3β,5,22,23-tetrahydroxy-5α-stigmastan-6-one. Their bioactivities were evaluated by the rice lamina inclination test. C-5α Fluorinated analogs showed excellent in vitro bioactivity, also revealed at low doses, while C-5α hydroxylated analogs resulted in an important decrease in bioactivity. Previously given explanations to justify the decreasing effect due to C-5α electronegative groups should be revised. (C) 2000 Elsevier Science Ltd. |
---|